[Successful induction of complete cytogenetic response with low-dose imatinib mesylate in an accelerated phase chronic myelogenous leukemia patient who developed severe bone marrow aplasia following standard-dose imatinib mesylate therapy].
Nakazato
Tomonori
T
Dept. of Hematology, Yokohama Municipal Citizens Hospital.
Suzuki
Kazuhito
K
Mihara
Ai
A
Sanada
Yukinari
Y
Kakimoto
Tsunayuki
T